Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
DYNAVAX TECHNOLOGIES CORP (DVAX)
Sector: Healthcare; Industry: Biotechnology

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Dynavax Technologies Corporation has partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against COVID-19 infection; and a collaboration with Valneva SE to initiate a vaccine program for the coronavirus, COVID-19. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-07-17 Janssen Robert Senior Vice President Sell 50,000 $11.09 $554,500 No
2020-05-27 Hack Andrew A. F. Director Buy 1,000,000 $5.00 $5,000,000 No
2020-05-19 Janssen Robert Senior Vice President Sell 15,000 $6.33 $94,950 No
2020-05-06 Janssen Robert Senior Vice President Sell 37,000 $4.50 $166,430 No
2019-08-12 Phillips Peggy V Director Buy 16,666 $3.00 $49,998 Yes
2019-08-12 CANO FRANCIS Director Buy 16,667 $3.00 $50,001 Yes
2019-08-12 Novack David F Co-President and Senior VP Buy 16,667 $3.00 $50,001 Yes
2019-06-04 COFFMAN ROBERT Senior Vice President Sell 32,218 $4.58 $147,687 Yes
2019-02-28 OSTRACH MICHAEL S Senior Vice President Sell 35,444 $8.94 $316,764 Yes
2019-02-28 Johnson David Louis Vice President Sell 20,765 $9.03 $187,508 No
2019-02-28 COFFMAN ROBERT Senior Vice President Sell 63,202 $9.03 $570,714 No
2019-02-28 OSTRACH MICHAEL S Senior Vice President Sell 35,444 $8.94 $316,764 Yes
2018-12-06 CANO FRANCIS Director Sell 2,000 $10.47 $20,942 No
2018-06-08 OSTRACH MICHAEL S Senior Vice President Sell 4,000 $15.53 $62,100 No
2018-03-15 Novack David F Senior Vice President Sell 16,109 $16.30 $262,604 No
2018-03-13 Novack David F Senior Vice President Sell 34,214 $16.52 $565,105 No
2018-03-09 Novack David F Senior Vice President Sell 2,121 $17.97 $38,111 No
2018-01-04 Johnson David Louis Vice President Sell 3,092 $18.60 $57,511 No
2018-01-04 Johnson David Louis Vice President Sell 3,092 $18.60 $57,511 No
2017-12-13 COFFMAN ROBERT Senior Vice President Sell 7,500 $18.90 $141,750 Yes
2017-01-24 Janssen Robert Vice President Buy 6,000 $4.04 $24,240 No
2016-06-28 Janssen Robert Vice President Buy 1,452 $13.68 $19,863 No
2016-05-20 Gray Eddie CEO and Director Buy 2,750 $15.57 $42,820 No
2016-05-12 Janssen Robert Vice President Buy 1,000 $15.12 $15,120 No
2015-10-08 Janssen Robert Vice President Buy 100 $23.34 $2,334 No
2014-08-14 Gray Eddie CEO and Director Buy 25,000 $1.49 $37,250 No
2013-10-30 KISNER DANIEL L Director Buy 10,000 $1.07 $10,750 No
2013-10-30 ORONSKY ARNOLD L Director Buy 186,047 $1.07 $200,001 No
2013-10-30 Phillips Peggy V Director Buy 93,023 $1.07 $100,000 No
2012-11-06 COFFMAN ROBERT Chief Scientific Officer & VP Sell 8,000 $4.31 $34,480 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.